Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I single-center, double-blinded, randomized clinical trial of SB208 16% in female patients with Onychomycosis

Trial Profile

Phase I single-center, double-blinded, randomized clinical trial of SB208 16% in female patients with Onychomycosis

Completed
Phase of Trial: Phase I

Latest Information Update: 24 May 2018

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Onychomycosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 May 2018 New trial record
    • 17 May 2018 According to the Novan Inc media release, data from this study will be presented at the International Investigative Dermatology meeting 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top